Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation

Transplantation

Volumn 63, Issue 10, 1997, Pages 1415-1419

  Singh, Nina ^a,b   Gayowski, Timothy ^b   Wannstedt, Cheryl F ^b   Wagener, Marilyn M ^b   Marino, Ignazio R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; HEPATITIS B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; SEROCONVERSION; VIRUS REPLICATION;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREMEDICATION; TREATMENT OUTCOME;

EID: 0030914454     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705270-00008     Document Type: Article

References (17)

1. Samuel D, Bismuth H, Mathieu D, et al. Passive immunopro phylaxis after liver transplantation in HBsAg positive patients. Lancet 1991; 1: 813.
2. VanThiel DH, Wright HI, Fagiuoli S. Liver transplantation for hepatitis B virus-associated cirrhosis: a progress report. Hepatology 1994; 20 (1, Pt 2): 20S.
3. Weisner RH. Recurrence of liver disease following liver transplantation. Transplantation 1996; 12: 4.
4. Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon-alpha 2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295.
5. Gibas AL. Use of interferon in the treatment of chronic viral hepatitis. Gastroenterology 1993; 1: 129.
6. Korba BE, Milman G. A cell culture assay for compounds which inhibit hepatitis B virus replication. Research 1991; 15: 217.
7. Pue MA, Benet LZ. Pharmacokinetics of famciclovir in man. Antiviral Res Chemother 1993; 4: 47.
8. Shaw T, Amor P, Civitico G, Boyd M, Locarini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside against duck hepatitis B virus. Antimicrob Agents Chemother 1994; 38: 719.
9. Tsiquaye KN, Slomka MJ, Maung M. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ova. J Med Virol 1990; 42: 306.
10. Vere Hodge RA. Famciclovir and penciclovir: the mode of action of famciclovir including its conversion to penciclovir. Antiviral Res Chemother 1993; 4: 67.
11. Boker KHW, Ringe B, Druger M, Richlmayr R, Manns MP. Prostaglandin E plus famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994; 12: 1706.
12. Kruger M, Tillmann HL, Trautwein C, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg 1996; 2: 253.
13. Main J, Brown JL, Karayiannis P, et al. A double-blind, placebo controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection [Abstract P1C1-38]. Presented at the 29th Antiviral Meeting of the European Association for the Study of the Liver, 1994, Athens-Vouliagineni-Greece.
14. Neiderman C, Heintges T, Lange S, et al. Long-term followup of HBeAg-positive patients treated with interferon-alpha for chronic hepatitis B. N Engl J Med 1996; 334: 1422.
15. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333; 1657.
16. Bain VG, Kneteman NM, Ma MA, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
17. Perrillo R, Rakela J, Martin P, et al. Lamivudine for hepatitis B after liver transplantation [Abstract]. Hepatology 1996; 24 (4, Pt 2): 182A.